These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8782740)

  • 21. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.
    Castelli C; Ciupitu AM; Rini F; Rivoltini L; Mazzocchi A; Kiessling R; Parmiani G
    Cancer Res; 2001 Jan; 61(1):222-7. PubMed ID: 11196165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical biology of antigen presentation by MHC molecules.
    van Kasteren SI; Overkleeft H; Ovaa H; Neefjes J
    Curr Opin Immunol; 2014 Feb; 26():21-31. PubMed ID: 24556397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allele-dependent association of chicken MHC class I molecules with the invariant chain.
    Chen F; Pan L; Zhang J; Zhou X; Li J; Yu W
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):273-80. PubMed ID: 24948007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential HLA class I and class II epitope precursors associated with heat shock protein 70 (HSPA).
    Stocki P; Morris NJ; Preisinger C; Wang XN; Kolch W; Multhoff G; Dickinson AM
    Cell Stress Chaperones; 2010 Sep; 15(5):729-41. PubMed ID: 20358320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structures of an MHC class II molecule with covalently bound single peptides.
    Fremont DH; Hendrickson WA; Marrack P; Kappler J
    Science; 1996 May; 272(5264):1001-4. PubMed ID: 8638119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
    Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
    Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of antigenic peptides by products of the major histocompatibility complex.
    Fairchild PJ
    J Pept Sci; 1998 May; 4(3):182-94. PubMed ID: 9643627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selector function of MHC I molecules is determined by protein plasticity.
    Bailey A; Dalchau N; Carter R; Emmott S; Phillips A; Werner JM; Elliott T
    Sci Rep; 2015 Oct; 5():14928. PubMed ID: 26482009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of peptides to T cell allorecognition and allograft rejection.
    Benichou G; Fedoseyeva EV
    Int Rev Immunol; 1996; 13(3):231-43. PubMed ID: 8782744
    [No Abstract]   [Full Text] [Related]  

  • 32. Peptide exchange in MHC molecules.
    Jensen PE; Weber DA; Thayer WP; Westerman LE; Dao CT
    Immunol Rev; 1999 Dec; 172():229-38. PubMed ID: 10631949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCR recognition of peptide/MHC class II complexes and superantigens.
    Sundberg EJ; Deng L; Mariuzza RA
    Semin Immunol; 2007 Aug; 19(4):262-71. PubMed ID: 17560120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide binding motifs for MHC class I and II molecules.
    Biddison WE; Martin R
    Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1I. PubMed ID: 18432645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
    Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
    Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigen presentation and macrophages].
    Toubert A; Charron D
    Pathol Biol (Paris); 1997 Feb; 45(2):126-30. PubMed ID: 9247034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.